BEIJING--June 8, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--In the last 10 years, the average return on investment (ROI) in China's pharmaceutical research and development (R&D) market has declined, which creates an obstacle for China's small- and medium-sized developers of patterned drugs.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!